These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31193787)

  • 21. A prospective real-world study of the diffuse-type tenosynovial giant cell tumor patient journey: A 2-year observational analysis.
    Bernthal NM; Healey JH; Palmerini E; Bauer S; Schreuder H; Leithner A; Martin-Broto J; Gouin F; Lopez-Bastida J; Gelderblom H; Staals EL; Burke ZD; Geiger EJ; Spierenburg G; Laeis P; Beyerlein E; Ye X; van de Sande M
    J Surg Oncol; 2022 Dec; 126(8):1520-1532. PubMed ID: 36006054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant tenosynovial giant cell tumor of the leg: a radiologic-pathologic correlation and review of the literature.
    Richman DM; Bresler SC; Rosenthal MH; Howard SA
    J Clin Imaging Sci; 2015; 5():13. PubMed ID: 25861547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetabular Reconstruction in a Rare Case of Ligamentum Teres Tenosynovial Giant Cell Tumour (TGCT) Causing Extensive Destruction.
    Douvlis G; Tsiridis CA; Gamie Z; Mpintoudi A; Milonakis N; Kenanidis E; Tsiridis E
    Cureus; 2024 Jan; 16(1):e52171. PubMed ID: 38344527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Findings of Pigmented Villonodular Synovitis in a Dog.
    Dempsey LM; Maddox TW; Meiring T; Wustefeld-Janssens B; Comerford EJ
    Vet Comp Orthop Traumatol; 2018 Jul; 31(4):304-310. PubMed ID: 29864767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current Systemic Treatment Options for Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis: Targeting the CSF1/CSF1R Axis.
    Brahmi M; Vinceneux A; Cassier PA
    Curr Treat Options Oncol; 2016 Feb; 17(2):10. PubMed ID: 26820289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
    Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
    Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of tenosynovial giant cell tumour of the foot and ankle.
    Spierenburg G; Lancaster ST; van der Heijden L; Mastboom MJL; Gelderblom H; Pratap S; van de Sande MAJ; Gibbons CLMH
    Bone Joint J; 2021 Apr; 103-B(4):788-794. PubMed ID: 33789469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of a diffuse type tenosynovial giant cell tumor in the thoracic spine mimicking spinal metastasis by frozen recapping laminoplasty in a patient with thyroid cancer.
    Yonezawa N; Murakami H; Kato S; Hayashi H; Tsuchiya H
    Eur Spine J; 2018 Jul; 27(Suppl 3):526-532. PubMed ID: 29663145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenosynovial giant cell tumor: case report and review.
    Lucas DR
    Arch Pathol Lab Med; 2012 Aug; 136(8):901-6. PubMed ID: 22849738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extra-articular diffuse-type tenosynovial giant cell tumor with benign histological features resulting in fatal pulmonary metastases.
    Osanai T; Suzuki H; Hiraga H; Soma T; Nojima T
    J Orthop Surg (Hong Kong); 2017 Jan; 25(1):2309499017690323. PubMed ID: 28219303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of arthroscopic excision based on the distribution of the tenosynovial giant cell tumor around knee joint.
    Yoo HJ; Nam HS; Park SB; Lee YS
    Knee; 2023 Mar; 41():360-372. PubMed ID: 36848705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides.
    Cupp JS; Miller MA; Montgomery KD; Nielsen TO; O'Connell JX; Huntsman D; van de Rijn M; Gilks CB; West RB
    Am J Surg Pathol; 2007 Jun; 31(6):970-6. PubMed ID: 17527089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Giant cell tumor of tendon sheath, tenosynovial giant cell tumor, and pigmented villonodular synovitis: defining the presentation, surgical therapy and recurrence.
    Martin RC; Osborne DL; Edwards MJ; Wrightson W; McMasters KM
    Oncol Rep; 2000; 7(2):413-9. PubMed ID: 10671695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature.
    Giustini N; Bernthal NM; Bukata SV; Singh AS
    Clin Sarcoma Res; 2018; 8():14. PubMed ID: 30002809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity classification of Tenosynovial Giant Cell Tumours on MR imaging.
    Mastboom MJL; Verspoor FGM; Hanff DF; Gademan MGJ; Dijkstra PDS; Schreuder HWB; Bloem JL; van der Wal RJP; van de Sande MAJ
    Surg Oncol; 2018 Sep; 27(3):544-550. PubMed ID: 30217317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors.
    Palmerini E; Staals EL; Maki RG; Pengo S; Cioffi A; Gambarotti M; Picci P; Daolio PA; Parafioriti A; Morris C; Antonescu CR; Gronchi A; Casali PG; Donati DM; Ferrari S; Stacchiotti S
    Eur J Cancer; 2015 Jan; 51(2):210-7. PubMed ID: 25465190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenosynovial Giant Cell Tumor of Diffuse Type Mimicking Bony Metastasis Detected on F-18 FDG PET/CT.
    Chang KJ; Byun BH; Moon HS; Park J; Koh JS; Kim BI; Lim SM
    Nucl Med Mol Imaging; 2014 Sep; 48(3):230-2. PubMed ID: 25177381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fine-needle aspiration cytology of diffuse type tenosynovial giant cell tumor with malignant trasformation and review of literature.
    Shafi S; MacDonald W; Satturwar S
    Diagn Cytopathol; 2024 Jun; ():. PubMed ID: 38932656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.
    Takeuchi A; Nomura A; Yamamoto N; Hayashi K; Igarashi K; Tandai S; Kawai A; Matsumine A; Miwa S; Nishida Y; Nakamura T; Terauchi R; Hoshi M; Kunisada T; Endo M; Yoshimura K; Murayama T; Tsuchiya H
    BMC Musculoskelet Disord; 2019 Feb; 20(1):68. PubMed ID: 30738433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenosynovial Giant Cell Tumor: Incidence, Prevalence, Patient Characteristics, and Recurrence. A Registry-based Cohort Study in Denmark.
    Ehrenstein V; Andersen SL; Qazi I; Sankar N; Pedersen AB; Sikorski R; Acquavella JF
    J Rheumatol; 2017 Oct; 44(10):1476-1483. PubMed ID: 28765257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.